🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 68620A203 (prev. 62620A104 )
- Market Cap
- Micro Cap
- Previous Symbol
- ONVO (changed 4/2/2025)
- Previous Name
- Organovo Holdings, Inc.
Business: VivoSim Labs, Inc. designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. The Company is collaborating with pharmaceutical and academic partners to develop human biological disease models in three dimensions.
Notes: Aug. 17, 2020 -- Organovo Holdings, Inc. (the “Company”) (Nasdaq: ONVO) today announced that it filed a certificate of second amendment to its certificate of incorporation with the Secretary of State of the State of Delaware to effect a 1-for-20 reverse stock split of its common stock. The shares underlying the Company’s outstanding options and restricted stock unit awards will also be adjusted accordingly. The reverse stock split will take effect at 5:00 pm (Eastern Time) on August 18, 2020, and the Company’s common stock will open for trading on The Nasdaq Capital Market on August 19, 2020 on a post-split basis. ading of the Company’s common stock on The Nasdaq Capital Market will continue, on a split-adjusted basis, with the opening of the markets on Wednesday, August 19, 2020, under the existing ticker symbol “ONVO” but with a new CUSIP number 68620A203. The reverse stock split reduces the number of shares of the Company’s common stock outstanding from approximately 130.6 million pre-reverse stock split shares to approximately 6.5 million post-reverse stock split shares.
Company Contact
- CEO
- Keith Murphy
- CFO
- Thomas P. Hess
- Headquarters
- 11555 Sorrento Valley Rd, Suite 100, San Diego, CA 92121
- Phone
- 858-224-1000
- Investor Relations
- Taylor J. Crouch · 858-224-1000 · info@vivosim.ai